|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:FOXK2-ABCA5 (FusionGDB2 ID:30991) |
Fusion Gene Summary for FOXK2-ABCA5 |
Fusion gene summary |
Fusion gene information | Fusion gene name: FOXK2-ABCA5 | Fusion gene ID: 30991 | Hgene | Tgene | Gene symbol | FOXK2 | ABCA5 | Gene ID | 3607 | 23461 |
Gene name | forkhead box K2 | ATP binding cassette subfamily A member 5 | |
Synonyms | ILF|ILF-1|ILF1|nGTBP | ABC13|EST90625|HTC3 | |
Cytomap | 17q25.3 | 17q24.3 | |
Type of gene | protein-coding | protein-coding | |
Description | forkhead box protein K2FOXK1G/T-mismatch specific binding proteincellular transcription factor ILF-1interleukin enhancer-binding factor 1 | ATP-binding cassette sub-family A member 5ATP-binding cassette A5ATP-binding cassette, sub-family A (ABC1), member 5 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q01167 | Q8WWZ7 | |
Ensembl transtripts involved in fusion gene | ENST00000335255, ENST00000529652, | ENST00000392676, ENST00000392677, ENST00000588877, ENST00000589609, | |
Fusion gene scores | * DoF score | 31 X 14 X 13=5642 | 5 X 6 X 3=90 |
# samples | 34 | 5 | |
** MAII score | log2(34/5642*10)=-4.05260001444787 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/90*10)=-0.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: FOXK2 [Title/Abstract] AND ABCA5 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | FOXK2(80542064)-ABCA5(67273983), # samples:3 | ||
Anticipated loss of major functional domain due to fusion event. | FOXK2-ABCA5 seems lost the major protein functional domain in Hgene partner, which is a transcription factor due to the frame-shifted ORF. FOXK2-ABCA5 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. FOXK2-ABCA5 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | FOXK2 | GO:0045892 | negative regulation of transcription, DNA-templated | 20810654|25451922 |
Hgene | FOXK2 | GO:0045893 | positive regulation of transcription, DNA-templated | 22083952 |
Hgene | FOXK2 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 9065434 |
Fusion gene breakpoints across FOXK2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across ABCA5 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BRCA | TCGA-D8-A27N-01A | FOXK2 | chr17 | 80542064 | + | ABCA5 | chr17 | 67273983 | - |
ChimerDB4 | BRCA | TCGA-D8-A27N-01A | FOXK2 | chr17 | 80542064 | + | ABCA5 | chr17 | 67273983 | - |
ChimerDB4 | BRCA | TCGA-D8-A27N-01A | FOXK2 | chr17 | 80542064 | + | ABCA5 | chr17 | 67270269 | - |
ChimerDB4 | BRCA | TCGA-D8-A27N-01A | FOXK2 | chr17 | 80542064 | - | ABCA5 | chr17 | 67273983 | - |
Top |
Fusion Gene ORF analysis for FOXK2-ABCA5 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000335255 | ENST00000392676 | FOXK2 | chr17 | 80542064 | + | ABCA5 | chr17 | 67273983 | - |
In-frame | ENST00000335255 | ENST00000392677 | FOXK2 | chr17 | 80542064 | + | ABCA5 | chr17 | 67273983 | - |
In-frame | ENST00000335255 | ENST00000588877 | FOXK2 | chr17 | 80542064 | + | ABCA5 | chr17 | 67273983 | - |
5CDS-intron | ENST00000335255 | ENST00000589609 | FOXK2 | chr17 | 80542064 | + | ABCA5 | chr17 | 67273983 | - |
intron-3CDS | ENST00000529652 | ENST00000392676 | FOXK2 | chr17 | 80542064 | + | ABCA5 | chr17 | 67273983 | - |
intron-3CDS | ENST00000529652 | ENST00000392677 | FOXK2 | chr17 | 80542064 | + | ABCA5 | chr17 | 67273983 | - |
intron-3CDS | ENST00000529652 | ENST00000588877 | FOXK2 | chr17 | 80542064 | + | ABCA5 | chr17 | 67273983 | - |
intron-intron | ENST00000529652 | ENST00000589609 | FOXK2 | chr17 | 80542064 | + | ABCA5 | chr17 | 67273983 | - |
Frame-shift | ENST00000335255 | ENST00000392676 | FOXK2 | chr17 | 80542064 | + | ABCA5 | chr17 | 67270269 | - |
Frame-shift | ENST00000335255 | ENST00000392677 | FOXK2 | chr17 | 80542064 | + | ABCA5 | chr17 | 67270269 | - |
Frame-shift | ENST00000335255 | ENST00000588877 | FOXK2 | chr17 | 80542064 | + | ABCA5 | chr17 | 67270269 | - |
5CDS-intron | ENST00000335255 | ENST00000589609 | FOXK2 | chr17 | 80542064 | + | ABCA5 | chr17 | 67270269 | - |
intron-3CDS | ENST00000529652 | ENST00000392676 | FOXK2 | chr17 | 80542064 | + | ABCA5 | chr17 | 67270269 | - |
intron-3CDS | ENST00000529652 | ENST00000392677 | FOXK2 | chr17 | 80542064 | + | ABCA5 | chr17 | 67270269 | - |
intron-3CDS | ENST00000529652 | ENST00000588877 | FOXK2 | chr17 | 80542064 | + | ABCA5 | chr17 | 67270269 | - |
intron-intron | ENST00000529652 | ENST00000589609 | FOXK2 | chr17 | 80542064 | + | ABCA5 | chr17 | 67270269 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000335255 | FOXK2 | chr17 | 80542064 | + | ENST00000392676 | ABCA5 | chr17 | 67273983 | - | 7216 | 1453 | 111 | 3989 | 1292 |
ENST00000335255 | FOXK2 | chr17 | 80542064 | + | ENST00000392677 | ABCA5 | chr17 | 67273983 | - | 7095 | 1453 | 111 | 3992 | 1293 |
ENST00000335255 | FOXK2 | chr17 | 80542064 | + | ENST00000588877 | ABCA5 | chr17 | 67273983 | - | 4576 | 1453 | 111 | 3989 | 1292 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000335255 | ENST00000392676 | FOXK2 | chr17 | 80542064 | + | ABCA5 | chr17 | 67273983 | - | 4.77E-05 | 0.9999523 |
ENST00000335255 | ENST00000392677 | FOXK2 | chr17 | 80542064 | + | ABCA5 | chr17 | 67273983 | - | 2.90E-05 | 0.99997103 |
ENST00000335255 | ENST00000588877 | FOXK2 | chr17 | 80542064 | + | ABCA5 | chr17 | 67273983 | - | 0.000162785 | 0.99983716 |
Top |
Fusion Genomic Features for FOXK2-ABCA5 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for FOXK2-ABCA5 |
Go to FGviewer for the breakpoints of chr17:80542064-chr17:67273983 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
FOXK2 | ABCA5 |
FUNCTION: Transcriptional regulator involved in different processes such as glucose metabolism, aerobic glycolysis and autophagy (By similarity). Recognizes and binds the forkhead DNA sequence motif (5'-GTAAACA-3') and can both act as a transcription activator or repressor, depending on the context (PubMed:22083952, PubMed:25451922). Together with FOXK1, acts as a key regulator of metabolic reprogramming towards aerobic glycolysis, a process in which glucose is converted to lactate in the presence of oxygen (By similarity). Acts by promoting expression of enzymes for glycolysis (such as hexokinase-2 (HK2), phosphofructokinase, pyruvate kinase (PKLR) and lactate dehydrogenase), while suppressing further oxidation of pyruvate in the mitochondria by up-regulating pyruvate dehydrogenase kinases PDK1 and PDK4 (By similarity). Probably plays a role in gluconeogenesis during overnight fasting, when lactate from white adipose tissue and muscle is the main substrate (By similarity). Together with FOXK1, acts as a negative regulator of autophagy in skeletal muscle: in response to starvation, enters the nucleus, binds the promoters of autophagy genes and represses their expression, preventing proteolysis of skeletal muscle proteins (By similarity). In addition to the 5'-GTAAACA-3' DNA motif, also binds the 5'-TGANTCA-3' palindromic DNA motif, and co-associates with JUN/AP-1 to activate transcription (PubMed:22083952). Also able to bind to a minimal DNA heteroduplex containing a G/T-mismatch with 5'-TRT[G/T]NB-3' sequence (PubMed:20097901). Binds to NFAT-like motifs (purine-rich) in the IL2 promoter (PubMed:1339390). Positively regulates WNT/beta-catenin signaling by translocating DVL proteins into the nucleus (PubMed:25805136). Also binds to HIV-1 long terminal repeat. May be involved in both positive and negative regulation of important viral and cellular promoter elements (PubMed:1909027). {ECO:0000250|UniProtKB:Q3UCQ1, ECO:0000269|PubMed:1339390, ECO:0000269|PubMed:1909027, ECO:0000269|PubMed:20097901, ECO:0000269|PubMed:22083952, ECO:0000269|PubMed:25451922, ECO:0000269|PubMed:25805136}. | FUNCTION: Cholesterol efflux transporter in macrophages that is responsible for APOAI/high-density lipoproteins (HDL) formation at the plasma membrane under high cholesterol levels and participates in reverse cholesterol transport (PubMed:25125465). May play a role in the processing of autolysosomes (By similarity). {ECO:0000250|UniProtKB:Q8K448, ECO:0000269|PubMed:25125465}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | FOXK2 | chr17:80542064 | chr17:67273983 | ENST00000335255 | + | 6 | 9 | 10_93 | 426.3333333333333 | 661.0 | Compositional bias | Note=Gly-rich |
Hgene | FOXK2 | chr17:80542064 | chr17:67273983 | ENST00000335255 | + | 6 | 9 | 258_353 | 426.3333333333333 | 661.0 | DNA binding | Fork-head |
Hgene | FOXK2 | chr17:80542064 | chr17:67273983 | ENST00000335255 | + | 6 | 9 | 54_128 | 426.3333333333333 | 661.0 | Domain | FHA |
Hgene | FOXK2 | chr17:80542064 | chr17:67273983 | ENST00000335255 | + | 6 | 9 | 300_318 | 426.3333333333333 | 661.0 | Region | DNA-binding%3B major groove |
Hgene | FOXK2 | chr17:80542064 | chr17:67273983 | ENST00000335255 | + | 6 | 9 | 328_332 | 426.3333333333333 | 661.0 | Region | DNA-binding%3B minor groove |
Hgene | FOXK2 | chr17:80542064 | chr17:67273983 | ENST00000335255 | + | 6 | 9 | 348_353 | 426.3333333333333 | 661.0 | Region | DNA-binding%3B minor groove |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000392676 | 17 | 39 | 1290_1533 | 797.3333333333334 | 1643.0 | Domain | ABC transporter 2 | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000588877 | 16 | 38 | 1290_1533 | 797.3333333333334 | 1643.0 | Domain | ABC transporter 2 | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000392676 | 17 | 39 | 1333_1340 | 797.3333333333334 | 1643.0 | Nucleotide binding | ATP 2 | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000588877 | 16 | 38 | 1333_1340 | 797.3333333333334 | 1643.0 | Nucleotide binding | ATP 2 | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000392676 | 17 | 39 | 1021_1041 | 797.3333333333334 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000392676 | 17 | 39 | 1071_1091 | 797.3333333333334 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000392676 | 17 | 39 | 1102_1122 | 797.3333333333334 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000392676 | 17 | 39 | 1139_1159 | 797.3333333333334 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000392676 | 17 | 39 | 1169_1189 | 797.3333333333334 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000392676 | 17 | 39 | 1207_1227 | 797.3333333333334 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000392676 | 17 | 39 | 866_886 | 797.3333333333334 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000392676 | 17 | 39 | 967_987 | 797.3333333333334 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000588877 | 16 | 38 | 1021_1041 | 797.3333333333334 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000588877 | 16 | 38 | 1071_1091 | 797.3333333333334 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000588877 | 16 | 38 | 1102_1122 | 797.3333333333334 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000588877 | 16 | 38 | 1139_1159 | 797.3333333333334 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000588877 | 16 | 38 | 1169_1189 | 797.3333333333334 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000588877 | 16 | 38 | 1207_1227 | 797.3333333333334 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000588877 | 16 | 38 | 866_886 | 797.3333333333334 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000588877 | 16 | 38 | 967_987 | 797.3333333333334 | 1643.0 | Transmembrane | Helical |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000392676 | 17 | 39 | 478_713 | 797.3333333333334 | 1643.0 | Domain | ABC transporter 1 | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000588877 | 16 | 38 | 478_713 | 797.3333333333334 | 1643.0 | Domain | ABC transporter 1 | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000392676 | 17 | 39 | 514_521 | 797.3333333333334 | 1643.0 | Nucleotide binding | ATP 1 | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000588877 | 16 | 38 | 514_521 | 797.3333333333334 | 1643.0 | Nucleotide binding | ATP 1 | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000392676 | 17 | 39 | 220_240 | 797.3333333333334 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000392676 | 17 | 39 | 264_284 | 797.3333333333334 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000392676 | 17 | 39 | 297_317 | 797.3333333333334 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000392676 | 17 | 39 | 328_348 | 797.3333333333334 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000392676 | 17 | 39 | 32_52 | 797.3333333333334 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000392676 | 17 | 39 | 355_375 | 797.3333333333334 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000392676 | 17 | 39 | 396_416 | 797.3333333333334 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000588877 | 16 | 38 | 220_240 | 797.3333333333334 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000588877 | 16 | 38 | 264_284 | 797.3333333333334 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000588877 | 16 | 38 | 297_317 | 797.3333333333334 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000588877 | 16 | 38 | 328_348 | 797.3333333333334 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000588877 | 16 | 38 | 32_52 | 797.3333333333334 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000588877 | 16 | 38 | 355_375 | 797.3333333333334 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr17:80542064 | chr17:67273983 | ENST00000588877 | 16 | 38 | 396_416 | 797.3333333333334 | 1643.0 | Transmembrane | Helical |
Top |
Fusion Gene Sequence for FOXK2-ABCA5 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000335255_ENST00000392676_TCGA-D8-A27N-01A_FOXK2_chr17_80542064_+_ABCA5_chr17_67273983_length(transcript)=7216nt_BP=1453nt CGGCCGCGCGTGCTCCCGCCCCTCGCCGCCGCTCGCTCGCTCGCCGGCCGGCGGCCTCCGCTCGGCCCCCTCCCTCAGCTCCGGTGCGCG GCGGCCGACGACCCGCGCGGCCTGGGCCTCGGCCCGCGCCACCGGCGCCCGCGCGGAGCGGCCCGGGGGCCCTCACGCAGGCCCATGGCG GCGGCCGCGGCGGCGCTCTCGGGCGCGGGCACGCCACCCGCGGGCGGCGGGGCCGGGGGCGGCGGGGCCGGGGGCGGCGGGTCCCCGCCG GGCGGCTGGGCCGTGGCGCGCCTGGAGGGCCGCGAGTTCGAGTATCTGATGAAGAAGCGCTCGGTGACCATCGGCCGCAACTCGTCGCAG GGCTCGGTGGACGTGAGCATGGGCCACTCGAGCTTCATCTCCCGGCGCCACCTCGAGATCTTCACGCCCCCGGGCGGCGGCGGCCATGGC GGGGCCGCTCCGGAGCTGCCGCCCGCGCAGCCCAGGCCCGACGCCGGCGGCGACTTCTACCTGCGCTGCTTGGGCAAGAACGGGGTATTC GTGGACGGCGTGTTCCAGAGGCGCGGGGCGCCGCCGCTGCAGCTGCCGCGCGTGTGCACATTCAGGTTCCCGAGCACAAACATCAAGATA ACGTTCACTGCCCTGTCCAGCGAGAAGAGAGAGAAGCAGGAGGCGTCTGAGTCTCCAGTGAAGGCCGTACAGCCACACATCTCGCCCCTG ACCATCAACATTCCAGACACCATGGCCCACCTCATCAGCCCTCTGCCCTCCCCCACGGGAACCATCAGCGCTGCAAACTCCTGCCCCTCC AGCCCCCGGGGAGCGGGGTCTTCAGGGTACAAGGTGGGCCGAGTGATGCCATCTGACCTCAATTTAATGGCTGACAACTCACAGCCTGAA AATGAAAAGGAAGCTTCAGGTGGAGACAGCCCGAAGGATGATTCAAAGCCGCCTTACTCCTACGCGCAGCTGATAGTTCAGGCGATTACG ATGGCTCCCGACAAACAGCTCACCCTGAACGGGATTTATACACACATCACTAAAAATTATCCCTACTACAGGACTGCGGACAAGGGCTGG CAGAATTCAATTCGCCACAATCTCTCTCTGAATCGTTATTTCATCAAAGTGCCGCGTTCCCAGGAAGAACCAGGCAAAGGCTCGTTCTGG AGGATAGACCCAGCCTCTGAAAGCAAATTAATAGAACAGGCTTTTAGGAAACGACGGCCTAGGGGCGTGCCCTGCTTTAGAACCCCTCTG GGACCGCTCTCTTCTAGGAGTGCCCCAGCCTCTCCCAATCACGCGGGAGTGCTGTCTGCTCACTCTAGTGGCGCCCAGACCCCTGAGAGC CTGTCGAGGGAAGGTTCGCCGGCCCCCCTGGAGCCTGAGCCTGGCGCTGCACAGCCCAAACTCGCTGTCATCCAGGAAGCCCGGTTTGCC CAGAGCGCCCCAGATTATAGTGTATTTACTCAGCAGCCACTGGAGGAAGAAATGGATTCAAAATCTTTTGATGAAATGGAACAGAGCTTA CTTATTCTTTCTGAAACCAAGGCTGCTCTAGTGAGCACCATGAGCCTTTGGAAACAACAGATGTATACAATAGCAAAGTTTCATTTCTTT ACCTTGAAACGTGAAAGTAAATCAGTGAGATCAGTGTTGCTTCTGCTTTTAATTTTTTTCACAGTTCAGATTTTTATGTTTTTGGTTCAT CACTCTTTTAAAAATGCTGTGGTTCCCATCAAACTTGTTCCAGACTTATATTTTCTAAAACCTGGAGACAAACCACATAAATACAAAACA AGTCTGCTTCTTCAAAATTCTGCTGACTCAGATATCAGTGATCTTATTAGCTTTTTCACAAGCCAGAACATAATGGTGACGATGATTAAT GACAGTGACTATGTATCCGTGGCTCCCCATAGTGCGGCTTTAAATGTGATGCATTCAGAAAAGGACTATGTTTTTGCAGCTGTTTTCAAC AGTACTATGGTTTATTCTTTACCTATATTAGTGAATATCATTAGTAACTACTATCTTTATCATTTAAATGTGACTGAAACCATCCAGATC TGGAGTACCCCATTCTTTCAAGAAATTACTGATATAGTTTTTAAAATTGAGCTGTATTTTCAAGCAGCTTTGCTTGGAATCATTGTTACT GCAATGCCACCTTACTTTGCCATGGAAAATGCAGAGAATCATAAGATCAAAGCTTATACTCAACTTAAACTTTCAGGTCTTTTGCCATCT GCATATTGGATTGGACAAGCTGTTGTTGATATCCCCTTATTTTTTATCATTCTTATTTTGATGCTAGGAAGCTTATTGGCATTTCATTAT GGATTATATTTTTATACTGTAAAGTTCCTTGCTGTGGTTTTTTGCCTTATTGGTTATGTTCCATCAGTTATTCTGTTCACTTATATTGCT TCTTTCACCTTTAAGAAAATTTTAAATACCAAAGAATTTTGGTCATTTATCTATTCTGTGGCAGCGTTGGCTTGTATTGCAATCACTGAA ATAACTTTCTTTATGGGATACACAATTGCAACTATTCTTCATTATGCCTTTTGTATCATCATTCCAATCTATCCACTTCTAGGTTGCCTG ATTTCTTTCATAAAGATTTCTTGGAAGAATGTACGAAAAAATGTGGACACCTATAATCCATGGGATAGGCTTTCAGTAGCTGTTATATCG CCTTACCTGCAGTGTGTACTGTGGATTTTCCTCTTACAATACTATGAGAAAAAATATGGAGGCAGATCAATAAGAAAAGATCCCTTTTTC AGAAACCTTTCAACGAAGTCTAAAAATAGGAAGCTTCCAGAACCACCAGACAATGAGGATGAAGATGAAGATGTCAAAGCTGAAAGACTA AAGGTCAAAGAGCTGATGGGTTGCCAGTGTTGTGAGGAGAAACCATCCATTATGGTCAGCAATTTGCATAAAGAATATGATGACAAGAAA GATTTTCTTCTTTCAAGAAAAGTAAAGAAAGTGGCAACTAAATACATCTCTTTCTGTGTGAAAAAAGGAGAGATCTTAGGACTATTGGGT CCAAATGGTGCTGGCAAAAGCACAATTATTAATATTCTGGTTGGTGATATTGAACCAACTTCAGGCCAGGTATTTTTAGGAGATTATTCT TCAGAGACAAGTGAAGATGATGATTCACTGAAGTGTATGGGTTACTGTCCTCAGATAAACCCTTTGTGGCCAGATACTACATTGCAGGAA CATTTTGAAATTTATGGAGCTGTCAAAGGAATGAGTGCAAGTGACATGAAAGAAGTCATAAGTCGAATAACACATGCACTTGATTTAAAA GAACATCTTCAGAAGACTGTAAAGAAACTACCTGCAGGAATCAAACGAAAGTTGTGTTTTGCTCTAAGTATGCTAGGGAATCCTCAGATT ACTTTGCTAGATGAACCATCTACAGGTATGGATCCCAAAGCCAAACAGCACATGTGGCGAGCAATTCGAACTGCATTTAAAAACAGAAAG CGGGCTGCTATTCTGACCACTCACTATATGGAGGAGGCAGAGGCTGTCTGTGATCGAGTAGCTATCATGGTGTCTGGGCAGTTAAGATGT ATCGGAACAGTACAACATCTAAAGAGTAAATTTGGAAAAGGCTACTTTTTGGAAATTAAATTGAAGGACTGGATAGAAAACCTAGAAGTA GACCGCCTTCAAAGAGAAATTCAGTATATTTTCCCAAATGCAAGCCGTCAGGAAAGTTTTTCTTCTATTTTGGCTTATAAAATTCCTAAG GAAGATGTTCAGTCCCTTTCACAATCTTTTTTTAAGCTGGAAGAAGCTAAACATGCTTTTGCCATTGAAGAATATAGCTTTTCTCAAGCA ACATTGGAACAGGTTTTTGTAGAACTCACTAAAGAACAAGAGGAGGAAGATAATAGTTGTGGAACTTTAAACAGCACACTTTGGTGGGAA CGAACACAAGAAGATAGAGTAGTATTTTGAATTTGTATTGTTCGGTCTGCTTACTGGGACTTCTTTCTTTTTCACTTAATTTTAACTTTG GTTTAAAAAGTTTTTTATTGGAATGGTAACTGGAGAACCAAGAACGCACTTGAAATTTTTCTAAGCTCCTTAATTGAAATGCTGTGGTTG TGTGTTTTGCTTTTCTTTAAATAAAACGTATGTATAATTAAGTGAAGCTGCATGTTTGTATTGAAGTATATTGAACTATATAGTTTGTAT GTCATCTTTTTCACCATTCAGAAACAGTGCTTCTGAATTTGTGATTTAAAGGAATTGTAATAGAATAGTTTTATTTTTAAGTTATCTTTA AGTTTATGCCATCTTCTTAAATAAGTACGTAATGTTCCAATCTAAATAAAAAACTAATTCATAACTAATGCATAGAAAAGATACATAAAG CAATGTGAAAGTTTCTTGCTTCTCCTTTTTAATTTCTAAAAAAGCCACTTTGAATGGAAGTTGTCATCCGTAAAAGCTGAAGTGTAAGCA CTAGGAAATCTCAATATAGAGATTTGAGGAAAGTTATATCCACTAGGTGGCAGTCATTGATCATAATAAGTGAAATGAGCCCTTGTTCTA GTACATGATTTTAGGCTTAGGTAATTAGGTATGTGAAATTACATTTCTTTAATTTAAAGTAAAATTCAGAAGGTTTTAGTTATTATAATT AAAGGAAGACTGTGTGTAGAATCTTACGTAATAGTCTGATTCTTTGACTCTGTGGCTAGAATGACAGTTATCTATGGAGGTGGTAGAATT AAGCCATACCTTTTCCTTCATCACTCTTGGAACATATAAATTTTTTGTCATCTTCCTTGCAAAGGGCACATTTAATTTTGTTCTTGAATA AAATATTTTATTGGGTATTTGTTTTTATTGGTAAACTTTAGTGAATCTCTTCTATAAAATTGTAAGTAGATCAGTGTGTAGATTTATTTA GTAACTTACCTCATTGACTTTGGAACATGGTAGGATATGAATAAACTCTTTCAAGGGTTAAATTAAGAATTGTAAGTGCAGTGCGCCTAT TTCTTTTTAATAAGAACCAGAATTTCATTTTTGATAGAGTTAAAGGCATGGCTAATATTTTCTTAGAAATACTTCCTTGTACAACCCATG TATTGGCTCAAGGTATAAAATAGTGTAAATAATGCTAGTTGACATTACATTTCAACCAAATGAAAGTATTAACTTCATAAAACAAATATA TTGAGAGTGTGATTATTGTATTAGACAACAACAACAGCAATGACAGAAGGATTTGGTACTGAATTACTTTAAATAAGCAAAACCTTTCAG TGGCATTATTCATTCTTTAATGTAGGCAAAATTTAATGAACTTTTAGCTTTATTGTGTAATAAGACATCTGTGATTTTAGGCTCTAGCAG TGGATTTAAAAGTGTTCTTTCTCGGTACAAAGTACGTGGCTGATATTTTCCCCCATTGCTGGGGGCAGTTGCTATACACTTTCCTAAAGT ATATATAATGTTCACATAAATACCCAGGGACCTCTTTTTTGGGATGTGCTTTTGTAATTATGTGTAACCTTGAATACTTAAGTTTAGTAA AAGCAACAAAATTATATCTATAGTTTACTAAGGCAGTCACGAAAAAGCATAGTTTTTTTTAGAACCTGACCATCCTAAGAAAGTTATGTC ATCTGAAGATAGAGCATGACTAATGAAGAAAATTACCTGCTTTTGCACGTAGATTTGGTAACTTTCACTTTACATTTGTGAATGTGTAAT TGGTGCAAAGTAAATTTTTTTTCCTGCAAAGTGAAAGTTGAGTAGTCACAATCATGTTATTTATTTTGTTCATTTAGTTACTTTGCTTTT AATGTATATGAATACATGCTCTTGTAAACAATTTTAAAAGACATTCAAATTTTTTTTTAGTTTTTATATACTCAGAATATATTTTGGTTG TTAAATTAAATTATGTTCCCTTTTTCACAGTAACAAAATCTGACTCAGGAGAAATATAACTTAATTCTTAGGAAAACAAGGGTAAGTGAG CTGGAAAGCAAAGGAGGCAAAAAGTGAAATATATTTATTTACAGTGTACAGTTCATGTTTATGAACATACTAATTTTAAAATGTCTTAAA TTACTGATCTCAAAACTTTTTTCTATGTCAGTACAGATAAATAAATAAATATACATATTAGGCAAAAGCAACATCACCAACCTTATATTT CCCATTCATGGTCAAATTTTCAAAGGAAAGTAAAAGCTGAGCTTTACTGAGTGAGTGTTTACTGACTAATAAGGCAAGAAAAAACATGAT GAGTGTACTTTACATCTTACTTTTGTGGGCTCTTAATTTTTTTCTCTAGTTTGTTTTCAGTAAAGACAGTGGGTTTTCTTTAAAATAATT TTTTTCTTTTAAATTTGCACAAATTATCTTAGGTCAGTATTTTGGTTTTAATCATTAAAACATTTTTAGAGTAATGTAATTTAACAAATA TTTTAAGTGATTATGTTTCCAGAAATGGATTCTTTGGAGAGAACTCGGATGACTATCAGTTTTGGCCCTGTAAGATCGTGGAGATCTGTA AGATAGATACTTATATAACTTACATAAAATATATATAATATATTACTTATATAACTTATATAACTAGCTATTATTTTATATAACTAACTA TAATATGACAAATCCTTTGCTAGTAGTACTAACAACGTTTTATAGGAGCACAATTAATTTTACTTAGGATAAGTGTTGTTATTATTGTTT TTATTGTTGTTCTGTTAGTTACTCAAAACTTCATTCTAATTGTGCCCTGAGTTTGTTAAAATACCATACTGTATTTTTGTGTAACATGTA AATAGGCATTAATTTTTGAGAAATAGAAATGTTTATCCTTAATGTATTTTTAATTTGCTAACATTGATTTTTTATTTTCTTTCCTGAAAT AGCTTATTTCCTAAAATGAAAGAATTTATTCTCAGATGAATAATTTTTATATCAGCTATTCTTATCAGGTAAAAGTTTAATTATTTTTTA TTTATAATATATGTAAGCAATTCTCAATGCTGCTCTTTAAGAAAAATAAATATGATTATATTAATAATAAGCTTTAAGAGTTGAAAATTT AAGACAAGTCATTTTGTATACTGAAGTGAATTCTTTGTTATTTAGTGCTGATAATTGAATAATGAGTAGCTCATATTAAAAATGATGCAA >In-frame_ENST00000335255_ENST00000392676_TCGA-D8-A27N-01A_FOXK2_chr17_80542064_+_ABCA5_chr17_67273983_length(amino acids)=1292AA_start in transcript=111_stop in transcript=3989 MGLGPRHRRPRGAARGPSRRPMAAAAAALSGAGTPPAGGGAGGGGAGGGGSPPGGWAVARLEGREFEYLMKKRSVTIGRNSSQGSVDVSM GHSSFISRRHLEIFTPPGGGGHGGAAPELPPAQPRPDAGGDFYLRCLGKNGVFVDGVFQRRGAPPLQLPRVCTFRFPSTNIKITFTALSS EKREKQEASESPVKAVQPHISPLTINIPDTMAHLISPLPSPTGTISAANSCPSSPRGAGSSGYKVGRVMPSDLNLMADNSQPENEKEASG GDSPKDDSKPPYSYAQLIVQAITMAPDKQLTLNGIYTHITKNYPYYRTADKGWQNSIRHNLSLNRYFIKVPRSQEEPGKGSFWRIDPASE SKLIEQAFRKRRPRGVPCFRTPLGPLSSRSAPASPNHAGVLSAHSSGAQTPESLSREGSPAPLEPEPGAAQPKLAVIQEARFAQSAPDYS VFTQQPLEEEMDSKSFDEMEQSLLILSETKAALVSTMSLWKQQMYTIAKFHFFTLKRESKSVRSVLLLLLIFFTVQIFMFLVHHSFKNAV VPIKLVPDLYFLKPGDKPHKYKTSLLLQNSADSDISDLISFFTSQNIMVTMINDSDYVSVAPHSAALNVMHSEKDYVFAAVFNSTMVYSL PILVNIISNYYLYHLNVTETIQIWSTPFFQEITDIVFKIELYFQAALLGIIVTAMPPYFAMENAENHKIKAYTQLKLSGLLPSAYWIGQA VVDIPLFFIILILMLGSLLAFHYGLYFYTVKFLAVVFCLIGYVPSVILFTYIASFTFKKILNTKEFWSFIYSVAALACIAITEITFFMGY TIATILHYAFCIIIPIYPLLGCLISFIKISWKNVRKNVDTYNPWDRLSVAVISPYLQCVLWIFLLQYYEKKYGGRSIRKDPFFRNLSTKS KNRKLPEPPDNEDEDEDVKAERLKVKELMGCQCCEEKPSIMVSNLHKEYDDKKDFLLSRKVKKVATKYISFCVKKGEILGLLGPNGAGKS TIINILVGDIEPTSGQVFLGDYSSETSEDDDSLKCMGYCPQINPLWPDTTLQEHFEIYGAVKGMSASDMKEVISRITHALDLKEHLQKTV KKLPAGIKRKLCFALSMLGNPQITLLDEPSTGMDPKAKQHMWRAIRTAFKNRKRAAILTTHYMEEAEAVCDRVAIMVSGQLRCIGTVQHL KSKFGKGYFLEIKLKDWIENLEVDRLQREIQYIFPNASRQESFSSILAYKIPKEDVQSLSQSFFKLEEAKHAFAIEEYSFSQATLEQVFV -------------------------------------------------------------- >In-frame_ENST00000335255_ENST00000392677_TCGA-D8-A27N-01A_FOXK2_chr17_80542064_+_ABCA5_chr17_67273983_length(transcript)=7095nt_BP=1453nt CGGCCGCGCGTGCTCCCGCCCCTCGCCGCCGCTCGCTCGCTCGCCGGCCGGCGGCCTCCGCTCGGCCCCCTCCCTCAGCTCCGGTGCGCG GCGGCCGACGACCCGCGCGGCCTGGGCCTCGGCCCGCGCCACCGGCGCCCGCGCGGAGCGGCCCGGGGGCCCTCACGCAGGCCCATGGCG GCGGCCGCGGCGGCGCTCTCGGGCGCGGGCACGCCACCCGCGGGCGGCGGGGCCGGGGGCGGCGGGGCCGGGGGCGGCGGGTCCCCGCCG GGCGGCTGGGCCGTGGCGCGCCTGGAGGGCCGCGAGTTCGAGTATCTGATGAAGAAGCGCTCGGTGACCATCGGCCGCAACTCGTCGCAG GGCTCGGTGGACGTGAGCATGGGCCACTCGAGCTTCATCTCCCGGCGCCACCTCGAGATCTTCACGCCCCCGGGCGGCGGCGGCCATGGC GGGGCCGCTCCGGAGCTGCCGCCCGCGCAGCCCAGGCCCGACGCCGGCGGCGACTTCTACCTGCGCTGCTTGGGCAAGAACGGGGTATTC GTGGACGGCGTGTTCCAGAGGCGCGGGGCGCCGCCGCTGCAGCTGCCGCGCGTGTGCACATTCAGGTTCCCGAGCACAAACATCAAGATA ACGTTCACTGCCCTGTCCAGCGAGAAGAGAGAGAAGCAGGAGGCGTCTGAGTCTCCAGTGAAGGCCGTACAGCCACACATCTCGCCCCTG ACCATCAACATTCCAGACACCATGGCCCACCTCATCAGCCCTCTGCCCTCCCCCACGGGAACCATCAGCGCTGCAAACTCCTGCCCCTCC AGCCCCCGGGGAGCGGGGTCTTCAGGGTACAAGGTGGGCCGAGTGATGCCATCTGACCTCAATTTAATGGCTGACAACTCACAGCCTGAA AATGAAAAGGAAGCTTCAGGTGGAGACAGCCCGAAGGATGATTCAAAGCCGCCTTACTCCTACGCGCAGCTGATAGTTCAGGCGATTACG ATGGCTCCCGACAAACAGCTCACCCTGAACGGGATTTATACACACATCACTAAAAATTATCCCTACTACAGGACTGCGGACAAGGGCTGG CAGAATTCAATTCGCCACAATCTCTCTCTGAATCGTTATTTCATCAAAGTGCCGCGTTCCCAGGAAGAACCAGGCAAAGGCTCGTTCTGG AGGATAGACCCAGCCTCTGAAAGCAAATTAATAGAACAGGCTTTTAGGAAACGACGGCCTAGGGGCGTGCCCTGCTTTAGAACCCCTCTG GGACCGCTCTCTTCTAGGAGTGCCCCAGCCTCTCCCAATCACGCGGGAGTGCTGTCTGCTCACTCTAGTGGCGCCCAGACCCCTGAGAGC CTGTCGAGGGAAGGTTCGCCGGCCCCCCTGGAGCCTGAGCCTGGCGCTGCACAGCCCAAACTCGCTGTCATCCAGGAAGCCCGGTTTGCC CAGAGCGCCCCAGATTATAGTGTATTTACTCAGCAGCCACTGGAGGAAGAAATGGATTCAAAATCTTTTGATGAAATGGAACAGAGCTTA CTTATTCTTTCTGAAACCAAGGCTGCTCTAGTGAGCACCATGAGCCTTTGGAAACAACAGATGTATACAATAGCAAAGTTTCATTTCTTT ACCTTGAAACGTGAAAGTAAATCAGTGAGATCAGTGTTGCTTCTGCTTTTAATTTTTTTCACAGTTCAGATTTTTATGTTTTTGGTTCAT CACTCTTTTAAAAATGCTGTGGTTCCCATCAAACTTGTTCCAGACTTATATTTTCTAAAACCTGGAGACAAACCACATAAATACAAAACA AGTCTGCTTCTTCAAAATTCTGCTGCAGACTCAGATATCAGTGATCTTATTAGCTTTTTCACAAGCCAGAACATAATGGTGACGATGATT AATGACAGTGACTATGTATCCGTGGCTCCCCATAGTGCGGCTTTAAATGTGATGCATTCAGAAAAGGACTATGTTTTTGCAGCTGTTTTC AACAGTACTATGGTTTATTCTTTACCTATATTAGTGAATATCATTAGTAACTACTATCTTTATCATTTAAATGTGACTGAAACCATCCAG ATCTGGAGTACCCCATTCTTTCAAGAAATTACTGATATAGTTTTTAAAATTGAGCTGTATTTTCAAGCAGCTTTGCTTGGAATCATTGTT ACTGCAATGCCACCTTACTTTGCCATGGAAAATGCAGAGAATCATAAGATCAAAGCTTATACTCAACTTAAACTTTCAGGTCTTTTGCCA TCTGCATATTGGATTGGACAAGCTGTTGTTGATATCCCCTTATTTTTTATCATTCTTATTTTGATGCTAGGAAGCTTATTGGCATTTCAT TATGGATTATATTTTTATACTGTAAAGTTCCTTGCTGTGGTTTTTTGCCTTATTGGTTATGTTCCATCAGTTATTCTGTTCACTTATATT GCTTCTTTCACCTTTAAGAAAATTTTAAATACCAAAGAATTTTGGTCATTTATCTATTCTGTGGCAGCGTTGGCTTGTATTGCAATCACT GAAATAACTTTCTTTATGGGATACACAATTGCAACTATTCTTCATTATGCCTTTTGTATCATCATTCCAATCTATCCACTTCTAGGTTGC CTGATTTCTTTCATAAAGATTTCTTGGAAGAATGTACGAAAAAATGTGGACACCTATAATCCATGGGATAGGCTTTCAGTAGCTGTTATA TCGCCTTACCTGCAGTGTGTACTGTGGATTTTCCTCTTACAATACTATGAGAAAAAATATGGAGGCAGATCAATAAGAAAAGATCCCTTT TTCAGAAACCTTTCAACGAAGTCTAAAAATAGGAAGCTTCCAGAACCACCAGACAATGAGGATGAAGATGAAGATGTCAAAGCTGAAAGA CTAAAGGTCAAAGAGCTGATGGGTTGCCAGTGTTGTGAGGAGAAACCATCCATTATGGTCAGCAATTTGCATAAAGAATATGATGACAAG AAAGATTTTCTTCTTTCAAGAAAAGTAAAGAAAGTGGCAACTAAATACATCTCTTTCTGTGTGAAAAAAGGAGAGATCTTAGGACTATTG GGTCCAAATGGTGCTGGCAAAAGCACAATTATTAATATTCTGGTTGGTGATATTGAACCAACTTCAGGCCAGGTATTTTTAGGAGATTAT TCTTCAGAGACAAGTGAAGATGATGATTCACTGAAGTGTATGGGTTACTGTCCTCAGATAAACCCTTTGTGGCCAGATACTACATTGCAG GAACATTTTGAAATTTATGGAGCTGTCAAAGGAATGAGTGCAAGTGACATGAAAGAAGTCATAAGTCGAATAACACATGCACTTGATTTA AAAGAACATCTTCAGAAGACTGTAAAGAAACTACCTGCAGGAATCAAACGAAAGTTGTGTTTTGCTCTAAGTATGCTAGGGAATCCTCAG ATTACTTTGCTAGATGAACCATCTACAGGTATGGATCCCAAAGCCAAACAGCACATGTGGCGAGCAATTCGAACTGCATTTAAAAACAGA AAGCGGGCTGCTATTCTGACCACTCACTATATGGAGGAGGCAGAGGCTGTCTGTGATCGAGTAGCTATCATGGTGTCTGGGCAGTTAAGA TGTATCGGAACAGTACAACATCTAAAGAGTAAATTTGGAAAAGGCTACTTTTTGGAAATTAAATTGAAGGACTGGATAGAAAACCTAGAA GTAGACCGCCTTCAAAGAGAAATTCAGTATATTTTCCCAAATGCAAGCCGTCAGGAAAGTTTTTCTTCTATTTTGGCTTATAAAATTCCT AAGGAAGATGTTCAGTCCCTTTCACAATCTTTTTTTAAGCTGGAAGAAGCTAAACATGCTTTTGCCATTGAAGAATATAGCTTTTCTCAA GCAACATTGGAACAGGTTTTTGTAGAACTCACTAAAGAACAAGAGGAGGAAGATAATAGTTGTGGAACTTTAAACAGCACACTTTGGTGG GAACGAACACAAGAAGATAGAGTAGTATTTTGAATTTGTATTGTTCGGTCTGCTTACTGGGACTTCTTTCTTTTTCACTTAATTTTAACT TTGGTTTAAAAAGTTTTTTATTGGAATGGTAACTGGAGAACCAAGAACGCACTTGAAATTTTTCTAAGCTCCTTAATTGAAATGCTGTGG TTGTGTGTTTTGCTTTTCTTTAAATAAAACGTATGTATAATTAAGTGAAGCTGCATGTTTGTATTGAAGTATATTGAACTATATAGTTTG TATGTCATCTTTTTCACCATTCAGAAACAGTGCTTCTGAATTTGTGATTTAAAGGAATTGTAATAGAATAGTTTTATTTTTAAGTTATCT TTAAGTTTATGCCATCTTCTTAAATAAGTACGTAATGTTCCAATCTAAATAAAAAACTAATTCATAACTAATGCATAGAAAAGATACATA AAGCAATGTGAAAGTTTCTTGCTTCTCCTTTTTAATTTCTAAAAAAGCCACTTTGAATGGAAGTTGTCATCCGTAAAAGCTGAAGTGTAA GCACTAGGAAATCTCAATATAGAGATTTGAGGAAAGTTATATCCACTAGGTGGCAGTCATTGATCATAATAAGTGAAATGAGCCCTTGTT CTAGTACATGATTTTAGGCTTAGGTAATTAGGTATGTGAAATTACATTTCTTTAATTTAAAGTAAAATTCAGAAGGTTTTAGTTATTATA ATTAAAGGAAGACTGTGTGTAGAATCTTACGTAATAGTCTGATTCTTTGACTCTGTGGCTAGAATGACAGTTATCTATGGAGGTGGTAGA ATTAAGCCATACCTTTTCCTTCATCACTCTTGGAACATATAAATTTTTTGTCATCTTCCTTGCAAAGGGCACATTTAATTTTGTTCTTGA ATAAAATATTTTATTGGGTATTTGTTTTTATTGGTAAACTTTAGTGAATCTCTTCTATAAAATTGTAAGTAGATCAGTGTGTAGATTTAT TTAGTAACTTACCTCATTGACTTTGGAACATGGTAGGATATGAATAAACTCTTTCAAGGGTTAAATTAAGAATTGTAAGTGCAGTGCGCC TATTTCTTTTTAATAAGAACCAGAATTTCATTTTTGATAGAGTTAAAGGCATGGCTAATATTTTCTTAGAAATACTTCCTTGTACAACCC ATGTATTGGCTCAAGGTATAAAATAGTGTAAATAATGCTAGTTGACATTACATTTCAACCAAATGAAAGTATTAACTTCATAAAACAAAT ATATTGAGAGTGTGATTATTGTATTAGACAACAACAACAGCAATGACAGAAGGATTTGGTACTGAATTACTTTAAATAAGCAAAACCTTT CAGTGGCATTATTCATTCTTTAATGTAGGCAAAATTTAATGAACTTTTAGCTTTATTGTGTAATAAGACATCTGTGATTTTAGGCTCTAG CAGTGGATTTAAAAGTGTTCTTTCTCGGTACAAAGTACGTGGCTGATATTTTCCCCCATTGCTGGGGGCAGTTGCTATACACTTTCCTAA AGTATATATAATGTTCACATAAATACCCAGGGACCTCTTTTTTGGGATGTGCTTTTGTAATTATGTGTAACCTTGAATACTTAAGTTTAG TAAAAGCAACAAAATTATATCTATAGTTTACTAAGGCAGTCACGAAAAAGCATAGTTTTTTTTAGAACCTGACCATCCTAAGAAAGTTAT GTCATCTGAAGATAGAGCATGACTAATGAAGAAAATTACCTGCTTTTGCACGTAGATTTGGTAACTTTCACTTTACATTTGTGAATGTGT AATTGGTGCAAAGTAAATTTTTTTTCCTGCAAAGTGAAAGTTGAGTAGTCACAATCATGTTATTTATTTTGTTCATTTAGTTACTTTGCT TTTAATGTATATGAATACATGCTCTTGTAAACAATTTTAAAAGACATTCAAATTTTTTTTTAGTTTTTATATACTCAGAATATATTTTGG TTGTTAAATTAAATTATGTTCCCTTTTTCACAGTAACAAAATCTGACTCAGGAGAAATATAACTTAATTCTTAGGAAAACAAGGGTAAGT GAGCTGGAAAGCAAAGGAGGCAAAAAGTGAAATATATTTATTTACAGTGTACAGTTCATGTTTATGAACATACTAATTTTAAAATGTCTT AAATTACTGATCTCAAAACTTTTTTCTATGTCAGTACAGATAAATAAATAAATATACATATTAGGCAAAAGCAACATCACCAACCTTATA TTTCCCATTCATGGTCAAATTTTCAAAGGAAAGTAAAAGCTGAGCTTTACTGAGTGAGTGTTTACTGACTAATAAGGCAAGAAAAAACAT GATGAGTGTACTTTACATCTTACTTTTGTGGGCTCTTAATTTTTTTCTCTAGTTTGTTTTCAGTAAAGACAGTGGGTTTTCTTTAAAATA ATTTTTTTCTTTTAAATTTGCACAAATTATCTTAGGTCAGTATTTTGGTTTTAATCATTAAAACATTTTTAGAGTAATGTAATTTAACAA ATATTTTAAGTGATTATGTTTCCAGAAATGGATTCTTTGGAGAGAACTCGGATGACTATCAGTTTTGGCCCTGTAAGATCGTGGAGATCT GTAAGATAGATACTTATATAACTTACATAAAATATATATAATATATTACTTATATAACTTATATAACTAGCTATTATTTTATATAACTAA CTATAATATGACAAATCCTTTGCTAGTAGTACTAACAACGTTTTATAGGAGCACAATTAATTTTACTTAGGATAAGTGTTGTTATTATTG TTTTTATTGTTGTTCTGTTAGTTACTCAAAACTTCATTCTAATTGTGCCCTGAGTTTGTTAAAATACCATACTGTATTTTTGTGTAACAT GTAAATAGGCATTAATTTTTGAGAAATAGAAATGTTTATCCTTAATGTATTTTTAATTTGCTAACATTGATTTTTTATTTTCTTTCCTGA AATAGCTTATTTCCTAAAATGAAAGAATTTATTCTCAGATGAATAATTTTTATATCAGCTATTCTTATCAGGTAAAAGTTTAATTATTTT >In-frame_ENST00000335255_ENST00000392677_TCGA-D8-A27N-01A_FOXK2_chr17_80542064_+_ABCA5_chr17_67273983_length(amino acids)=1293AA_start in transcript=111_stop in transcript=3992 MGLGPRHRRPRGAARGPSRRPMAAAAAALSGAGTPPAGGGAGGGGAGGGGSPPGGWAVARLEGREFEYLMKKRSVTIGRNSSQGSVDVSM GHSSFISRRHLEIFTPPGGGGHGGAAPELPPAQPRPDAGGDFYLRCLGKNGVFVDGVFQRRGAPPLQLPRVCTFRFPSTNIKITFTALSS EKREKQEASESPVKAVQPHISPLTINIPDTMAHLISPLPSPTGTISAANSCPSSPRGAGSSGYKVGRVMPSDLNLMADNSQPENEKEASG GDSPKDDSKPPYSYAQLIVQAITMAPDKQLTLNGIYTHITKNYPYYRTADKGWQNSIRHNLSLNRYFIKVPRSQEEPGKGSFWRIDPASE SKLIEQAFRKRRPRGVPCFRTPLGPLSSRSAPASPNHAGVLSAHSSGAQTPESLSREGSPAPLEPEPGAAQPKLAVIQEARFAQSAPDYS VFTQQPLEEEMDSKSFDEMEQSLLILSETKAALVSTMSLWKQQMYTIAKFHFFTLKRESKSVRSVLLLLLIFFTVQIFMFLVHHSFKNAV VPIKLVPDLYFLKPGDKPHKYKTSLLLQNSAADSDISDLISFFTSQNIMVTMINDSDYVSVAPHSAALNVMHSEKDYVFAAVFNSTMVYS LPILVNIISNYYLYHLNVTETIQIWSTPFFQEITDIVFKIELYFQAALLGIIVTAMPPYFAMENAENHKIKAYTQLKLSGLLPSAYWIGQ AVVDIPLFFIILILMLGSLLAFHYGLYFYTVKFLAVVFCLIGYVPSVILFTYIASFTFKKILNTKEFWSFIYSVAALACIAITEITFFMG YTIATILHYAFCIIIPIYPLLGCLISFIKISWKNVRKNVDTYNPWDRLSVAVISPYLQCVLWIFLLQYYEKKYGGRSIRKDPFFRNLSTK SKNRKLPEPPDNEDEDEDVKAERLKVKELMGCQCCEEKPSIMVSNLHKEYDDKKDFLLSRKVKKVATKYISFCVKKGEILGLLGPNGAGK STIINILVGDIEPTSGQVFLGDYSSETSEDDDSLKCMGYCPQINPLWPDTTLQEHFEIYGAVKGMSASDMKEVISRITHALDLKEHLQKT VKKLPAGIKRKLCFALSMLGNPQITLLDEPSTGMDPKAKQHMWRAIRTAFKNRKRAAILTTHYMEEAEAVCDRVAIMVSGQLRCIGTVQH LKSKFGKGYFLEIKLKDWIENLEVDRLQREIQYIFPNASRQESFSSILAYKIPKEDVQSLSQSFFKLEEAKHAFAIEEYSFSQATLEQVF -------------------------------------------------------------- >In-frame_ENST00000335255_ENST00000588877_TCGA-D8-A27N-01A_FOXK2_chr17_80542064_+_ABCA5_chr17_67273983_length(transcript)=4576nt_BP=1453nt CGGCCGCGCGTGCTCCCGCCCCTCGCCGCCGCTCGCTCGCTCGCCGGCCGGCGGCCTCCGCTCGGCCCCCTCCCTCAGCTCCGGTGCGCG GCGGCCGACGACCCGCGCGGCCTGGGCCTCGGCCCGCGCCACCGGCGCCCGCGCGGAGCGGCCCGGGGGCCCTCACGCAGGCCCATGGCG GCGGCCGCGGCGGCGCTCTCGGGCGCGGGCACGCCACCCGCGGGCGGCGGGGCCGGGGGCGGCGGGGCCGGGGGCGGCGGGTCCCCGCCG GGCGGCTGGGCCGTGGCGCGCCTGGAGGGCCGCGAGTTCGAGTATCTGATGAAGAAGCGCTCGGTGACCATCGGCCGCAACTCGTCGCAG GGCTCGGTGGACGTGAGCATGGGCCACTCGAGCTTCATCTCCCGGCGCCACCTCGAGATCTTCACGCCCCCGGGCGGCGGCGGCCATGGC GGGGCCGCTCCGGAGCTGCCGCCCGCGCAGCCCAGGCCCGACGCCGGCGGCGACTTCTACCTGCGCTGCTTGGGCAAGAACGGGGTATTC GTGGACGGCGTGTTCCAGAGGCGCGGGGCGCCGCCGCTGCAGCTGCCGCGCGTGTGCACATTCAGGTTCCCGAGCACAAACATCAAGATA ACGTTCACTGCCCTGTCCAGCGAGAAGAGAGAGAAGCAGGAGGCGTCTGAGTCTCCAGTGAAGGCCGTACAGCCACACATCTCGCCCCTG ACCATCAACATTCCAGACACCATGGCCCACCTCATCAGCCCTCTGCCCTCCCCCACGGGAACCATCAGCGCTGCAAACTCCTGCCCCTCC AGCCCCCGGGGAGCGGGGTCTTCAGGGTACAAGGTGGGCCGAGTGATGCCATCTGACCTCAATTTAATGGCTGACAACTCACAGCCTGAA AATGAAAAGGAAGCTTCAGGTGGAGACAGCCCGAAGGATGATTCAAAGCCGCCTTACTCCTACGCGCAGCTGATAGTTCAGGCGATTACG ATGGCTCCCGACAAACAGCTCACCCTGAACGGGATTTATACACACATCACTAAAAATTATCCCTACTACAGGACTGCGGACAAGGGCTGG CAGAATTCAATTCGCCACAATCTCTCTCTGAATCGTTATTTCATCAAAGTGCCGCGTTCCCAGGAAGAACCAGGCAAAGGCTCGTTCTGG AGGATAGACCCAGCCTCTGAAAGCAAATTAATAGAACAGGCTTTTAGGAAACGACGGCCTAGGGGCGTGCCCTGCTTTAGAACCCCTCTG GGACCGCTCTCTTCTAGGAGTGCCCCAGCCTCTCCCAATCACGCGGGAGTGCTGTCTGCTCACTCTAGTGGCGCCCAGACCCCTGAGAGC CTGTCGAGGGAAGGTTCGCCGGCCCCCCTGGAGCCTGAGCCTGGCGCTGCACAGCCCAAACTCGCTGTCATCCAGGAAGCCCGGTTTGCC CAGAGCGCCCCAGATTATAGTGTATTTACTCAGCAGCCACTGGAGGAAGAAATGGATTCAAAATCTTTTGATGAAATGGAACAGAGCTTA CTTATTCTTTCTGAAACCAAGGCTGCTCTAGTGAGCACCATGAGCCTTTGGAAACAACAGATGTATACAATAGCAAAGTTTCATTTCTTT ACCTTGAAACGTGAAAGTAAATCAGTGAGATCAGTGTTGCTTCTGCTTTTAATTTTTTTCACAGTTCAGATTTTTATGTTTTTGGTTCAT CACTCTTTTAAAAATGCTGTGGTTCCCATCAAACTTGTTCCAGACTTATATTTTCTAAAACCTGGAGACAAACCACATAAATACAAAACA AGTCTGCTTCTTCAAAATTCTGCTGACTCAGATATCAGTGATCTTATTAGCTTTTTCACAAGCCAGAACATAATGGTGACGATGATTAAT GACAGTGACTATGTATCCGTGGCTCCCCATAGTGCGGCTTTAAATGTGATGCATTCAGAAAAGGACTATGTTTTTGCAGCTGTTTTCAAC AGTACTATGGTTTATTCTTTACCTATATTAGTGAATATCATTAGTAACTACTATCTTTATCATTTAAATGTGACTGAAACCATCCAGATC TGGAGTACCCCATTCTTTCAAGAAATTACTGATATAGTTTTTAAAATTGAGCTGTATTTTCAAGCAGCTTTGCTTGGAATCATTGTTACT GCAATGCCACCTTACTTTGCCATGGAAAATGCAGAGAATCATAAGATCAAAGCTTATACTCAACTTAAACTTTCAGGTCTTTTGCCATCT GCATATTGGATTGGACAAGCTGTTGTTGATATCCCCTTATTTTTTATCATTCTTATTTTGATGCTAGGAAGCTTATTGGCATTTCATTAT GGATTATATTTTTATACTGTAAAGTTCCTTGCTGTGGTTTTTTGCCTTATTGGTTATGTTCCATCAGTTATTCTGTTCACTTATATTGCT TCTTTCACCTTTAAGAAAATTTTAAATACCAAAGAATTTTGGTCATTTATCTATTCTGTGGCAGCGTTGGCTTGTATTGCAATCACTGAA ATAACTTTCTTTATGGGATACACAATTGCAACTATTCTTCATTATGCCTTTTGTATCATCATTCCAATCTATCCACTTCTAGGTTGCCTG ATTTCTTTCATAAAGATTTCTTGGAAGAATGTACGAAAAAATGTGGACACCTATAATCCATGGGATAGGCTTTCAGTAGCTGTTATATCG CCTTACCTGCAGTGTGTACTGTGGATTTTCCTCTTACAATACTATGAGAAAAAATATGGAGGCAGATCAATAAGAAAAGATCCCTTTTTC AGAAACCTTTCAACGAAGTCTAAAAATAGGAAGCTTCCAGAACCACCAGACAATGAGGATGAAGATGAAGATGTCAAAGCTGAAAGACTA AAGGTCAAAGAGCTGATGGGTTGCCAGTGTTGTGAGGAGAAACCATCCATTATGGTCAGCAATTTGCATAAAGAATATGATGACAAGAAA GATTTTCTTCTTTCAAGAAAAGTAAAGAAAGTGGCAACTAAATACATCTCTTTCTGTGTGAAAAAAGGAGAGATCTTAGGACTATTGGGT CCAAATGGTGCTGGCAAAAGCACAATTATTAATATTCTGGTTGGTGATATTGAACCAACTTCAGGCCAGGTATTTTTAGGAGATTATTCT TCAGAGACAAGTGAAGATGATGATTCACTGAAGTGTATGGGTTACTGTCCTCAGATAAACCCTTTGTGGCCAGATACTACATTGCAGGAA CATTTTGAAATTTATGGAGCTGTCAAAGGAATGAGTGCAAGTGACATGAAAGAAGTCATAAGTCGAATAACACATGCACTTGATTTAAAA GAACATCTTCAGAAGACTGTAAAGAAACTACCTGCAGGAATCAAACGAAAGTTGTGTTTTGCTCTAAGTATGCTAGGGAATCCTCAGATT ACTTTGCTAGATGAACCATCTACAGGTATGGATCCCAAAGCCAAACAGCACATGTGGCGAGCAATTCGAACTGCATTTAAAAACAGAAAG CGGGCTGCTATTCTGACCACTCACTATATGGAGGAGGCAGAGGCTGTCTGTGATCGAGTAGCTATCATGGTGTCTGGGCAGTTAAGATGT ATCGGAACAGTACAACATCTAAAGAGTAAATTTGGAAAAGGCTACTTTTTGGAAATTAAATTGAAGGACTGGATAGAAAACCTAGAAGTA GACCGCCTTCAAAGAGAAATTCAGTATATTTTCCCAAATGCAAGCCGTCAGGAAAGTTTTTCTTCTATTTTGGCTTATAAAATTCCTAAG GAAGATGTTCAGTCCCTTTCACAATCTTTTTTTAAGCTGGAAGAAGCTAAACATGCTTTTGCCATTGAAGAATATAGCTTTTCTCAAGCA ACATTGGAACAGGTTTTTGTAGAACTCACTAAAGAACAAGAGGAGGAAGATAATAGTTGTGGAACTTTAAACAGCACACTTTGGTGGGAA CGAACACAAGAAGATAGAGTAGTATTTTGAATTTGTATTGTTCGGTCTGCTTACTGGGACTTCTTTCTTTTTCACTTAATTTTAACTTTG GTTTAAAAAGTTTTTTATTGGAATGGTAACTGGAGAACCAAGAACGCACTTGAAATTTTTCTAAGCTCCTTAATTGAAATGCTGTGGTTG TGTGTTTTGCTTTTCTTTAAATAAAACGTATGTATAATTAAGTGAAGCTGCATGTTTGTATTGAAGTATATTGAACTATATAGTTTGTAT GTCATCTTTTTCACCATTCAGAAACAGTGCTTCTGAATTTGTGATTTAAAGGAATTGTAATAGAATAGTTTTATTTTTAAGTTATCTTTA AGTTTATGCCATCTTCTTAAATAAGTACGTAATGTTCCAATCTAAATAAAAAACTAATTCATAACTAATGCATAGAAAAGATACATAAAG CAATGTGAAAGTTTCTTGCTTCTCCTTTTTAATTTCTAAAAAAGCCACTTTGAATGGAAGTTGTCATCCGTAAAAGCTGAAGTGTAAGCA >In-frame_ENST00000335255_ENST00000588877_TCGA-D8-A27N-01A_FOXK2_chr17_80542064_+_ABCA5_chr17_67273983_length(amino acids)=1292AA_start in transcript=111_stop in transcript=3989 MGLGPRHRRPRGAARGPSRRPMAAAAAALSGAGTPPAGGGAGGGGAGGGGSPPGGWAVARLEGREFEYLMKKRSVTIGRNSSQGSVDVSM GHSSFISRRHLEIFTPPGGGGHGGAAPELPPAQPRPDAGGDFYLRCLGKNGVFVDGVFQRRGAPPLQLPRVCTFRFPSTNIKITFTALSS EKREKQEASESPVKAVQPHISPLTINIPDTMAHLISPLPSPTGTISAANSCPSSPRGAGSSGYKVGRVMPSDLNLMADNSQPENEKEASG GDSPKDDSKPPYSYAQLIVQAITMAPDKQLTLNGIYTHITKNYPYYRTADKGWQNSIRHNLSLNRYFIKVPRSQEEPGKGSFWRIDPASE SKLIEQAFRKRRPRGVPCFRTPLGPLSSRSAPASPNHAGVLSAHSSGAQTPESLSREGSPAPLEPEPGAAQPKLAVIQEARFAQSAPDYS VFTQQPLEEEMDSKSFDEMEQSLLILSETKAALVSTMSLWKQQMYTIAKFHFFTLKRESKSVRSVLLLLLIFFTVQIFMFLVHHSFKNAV VPIKLVPDLYFLKPGDKPHKYKTSLLLQNSADSDISDLISFFTSQNIMVTMINDSDYVSVAPHSAALNVMHSEKDYVFAAVFNSTMVYSL PILVNIISNYYLYHLNVTETIQIWSTPFFQEITDIVFKIELYFQAALLGIIVTAMPPYFAMENAENHKIKAYTQLKLSGLLPSAYWIGQA VVDIPLFFIILILMLGSLLAFHYGLYFYTVKFLAVVFCLIGYVPSVILFTYIASFTFKKILNTKEFWSFIYSVAALACIAITEITFFMGY TIATILHYAFCIIIPIYPLLGCLISFIKISWKNVRKNVDTYNPWDRLSVAVISPYLQCVLWIFLLQYYEKKYGGRSIRKDPFFRNLSTKS KNRKLPEPPDNEDEDEDVKAERLKVKELMGCQCCEEKPSIMVSNLHKEYDDKKDFLLSRKVKKVATKYISFCVKKGEILGLLGPNGAGKS TIINILVGDIEPTSGQVFLGDYSSETSEDDDSLKCMGYCPQINPLWPDTTLQEHFEIYGAVKGMSASDMKEVISRITHALDLKEHLQKTV KKLPAGIKRKLCFALSMLGNPQITLLDEPSTGMDPKAKQHMWRAIRTAFKNRKRAAILTTHYMEEAEAVCDRVAIMVSGQLRCIGTVQHL KSKFGKGYFLEIKLKDWIENLEVDRLQREIQYIFPNASRQESFSSILAYKIPKEDVQSLSQSFFKLEEAKHAFAIEEYSFSQATLEQVFV -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for FOXK2-ABCA5 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for FOXK2-ABCA5 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for FOXK2-ABCA5 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | ABCA5 | C0009402 | Colorectal Carcinoma | 1 | CTD_human |
Tgene | ABCA5 | C0009404 | Colorectal Neoplasms | 1 | CTD_human |
Tgene | ABCA5 | C1851120 | Hypertrichosis Terminalis, Generalized, with or without Gingival Hyperplasia | 1 | CTD_human;ORPHANET |